Recent Finacing
Recent Raise
QRL Bioscience develops personalized living cell therapies for chronic degenerative conditions, advancing a diabetic foot ulcer candidate into clinical trials and an osteoarthritis program with supply-chain, clinical and distribution partnerships.
